Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Flurazepam
Drug ID BADD_D00939
Description A benzodiazepine derivative used mainly as a hypnotic.
Indications and Usage For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits
Marketing Status approved; illicit; investigational
ATC Code N05CD01
DrugBank ID DB00690
KEGG ID D00329
MeSH ID D005479
PubChem ID 3393
TTD Drug ID D08XFV
NDC Product Code Not Available
UNII IHP475989U
Synonyms Flurazepam | Dalmane | Dalmadorm | Dormodor | Flurazepam Hydrochloride | Hydrochloride, Flurazepam | Flurazepam Dihydrochloride | Dihydrochloride, Flurazepam | Flurazepam Monohydrochloride | Monohydrochloride, Flurazepam | Staurodorm | Apo-Flurazepam | Apo Flurazepam | Flurazepam Mono-Perchlorate | Flurazepam Mono Perchlorate | Mono-Perchlorate, Flurazepam
Chemical Information
Molecular Formula C21H23ClFN3O
CAS Registry Number 17617-23-1
SMILES CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Thinking abnormal17.02.05.023; 19.10.03.001---
Tinnitus04.04.01.002; 17.04.07.004--
Tremor17.01.06.002--
Urticaria10.01.06.001; 23.04.02.001--
Vision blurred06.02.06.007; 17.17.01.010--
Vomiting07.01.07.003--
Withdrawal syndrome08.06.02.012; 19.07.06.023---
Musculoskeletal discomfort15.03.04.001---
Blood alkaline phosphatase increased13.04.02.004--
Decreased appetite08.01.09.028; 14.03.01.005--
Drug intolerance08.06.01.013---
The 3th Page    First    Pre   3    Total 3 Pages